Logo
T

TransCode Therapeutics, Inc.

18 employees

TransCode Therapeutics is a pre-clinical biopharmaceutical company.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
RNA
Oncology
Health Care
Pattern Recognition Receptor
Metastasis
Checkpoint Inhibitor
Nucleic Acid Therapeutics
Orphan Disease Designation
Diagnostics
Therapeutics
mRNA vaccine
CRISPR

Date founded

2016

Funding rounds raised

Total raised

$1.1M

from 5 investors over 5 rounds

T

TransCode Therapeutics, Inc. raised undisclosed on April 5, 2023

Investors: National Institutes of Health

T

TransCode Therapeutics, Inc. raised $1.1M on June 1, 2022

Investors: National Cancer Institute

T

TransCode Therapeutics, Inc. raised undisclosed on August 5, 2021

Investors: National Institutes of Health

T

TransCode Therapeutics, Inc. raised undisclosed on July 12, 2021

Investors: Red Cedar Ventures

T

TransCode Therapeutics, Inc. raised undisclosed on August 4, 2014

Investors: Red Cedar Ventures

FAQ